Reaction
Intracranial Infection reporting signals
As of the last recalculation, Intracranial Infection appears in 121 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 484.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 26 | 484.1 | 485.2 |
| Daptomycin | 13 | 271.4 | 271.8 |
| Ganciclovir Sodium | 14 | 257.2 | 257.5 |
| Amphotericin B | 16 | 253.0 | 253.3 |
| Valganciclovir | 18 | 192.8 | 192.9 |
| Valganciclovir Hydrochloride | 18 | 192.8 | 192.9 |
| Meropenem | 25 | 168.6 | 168.8 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 158.4 | 158.5 |
| Ganciclovir | 8 | 143.9 | 144.0 |
| Voriconazole Injection | 14 | 125.3 | 125.4 |
| Crizotinib | 4 | 55.9 | 56.0 |